Section Arrow
STIM.NASDAQ
- Neuronetics
Quotes are at least 15-min delayed:2026/01/22 16:33 EST
After Hours
Last
 2.21
+0.01 (+0.45%)
Bid
2.16
Ask
2.2
High 2.21 
Low 2.2 
Volume 1.74K 
Regular Hours (Closed)
Last
 2.2
+0.21 (+10.55%)
Day High 
2.24 
Prev. Close
1.99 
1-M High
2.125 
Volume 
1.66M 
Bid
2.16
Ask
2.2
Day Low
1.99 
Open
2.02 
1-M Low
1.26 
Market Cap 
136.29M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.9 
20-SMA 1.68 
50-SMA 1.61 
52-W High 5.92 
52-W Low 1.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.83/-0.32
Enterprise Value
214.12M
Balance Sheet
Book Value Per Share
0.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
74.89M
Operating Revenue Per Share
1.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories108.61-12.12-10.04%15.3PE
After Hours 108.89 +0.28 +0.26%
BSXBoston Scientific Corp91.29-0.42-0.46%49.04PE
After Hours 90.8 -0.49 -0.54%
DXCMDexCom73.92+1.81+2.51%39.94PE
After Hours 74.85 +0.93 +1.26%
PACBPacific Biosciences of California2.67+0.25+10.33%-- 
After Hours 2.65 -0.02 -0.75%
MDTMedtronic plc101.34+1.05+1.05%27.2PE
After Hours 102 +0.66 +0.65%
Industry overview quotes are at least 15 minutes delayed
Business Description
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.